Tickertape - Financial freedom begins here

Revenue growth during the quarter was driven by Finished Dosages (FD) segment in North America and Europe. Profit before tax (PBT) jumped 32.36% YoY to Rs 202.23 crore during the quarter. EBITDA stood at Rs 308.1 crore, registering the growth of 34% compared with Rs 230.3 crore in Q3 FY25. EBITDA margin improved to 22% in Q3 FY26 as against 20% in Q3 FY25. For Q3 FY26, Finished Dosages, Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI), and Peptides/CDMO contributed 76%, 11%, 11%, and 2% of revenue from operations, respectively. Net debt stood at Rs 1,015.1 crore and Net debt to EBITDA at 0.91x in Q3 FY26. Krishna Prasad Chigurupati, chairman & managing director of Granules India said, 'Q3 has been one of our strongest quarters, reflecting disciplined execution of strategic growth initiatives and we are well positioned for sustained growth momentum. Our strong financial performance, on-going R&D investments, combined with advances in ESG stewardship and our expanding global supply footprint, reinforces our commitment to building a resilient, innovation-led pharmaceutical platform that delivers long-term value for all stakeholders.' Granules India is primarily involved in the manufacturing and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). The scrip declined 1.09% to end at Rs 564.95 on the BSE.Powered by Capital Market - Live

Net interest income jumped 31% to Rs 1,227 crore in the December'25 quarter from Rs 940 crore recorded in the December'24 quarter. NIM expanded by 51 bps YoY during the quarter to 6.3%. Total income increased by 29% YoY to Rs 1,480 crore in Q3 FY26. Operating expenses for the period under review added up to Rs 821 crore, up 4% YoY. Accordingly, operating profit was Rs 659 crore for Q3 FY26, up 84% YoY. The NBFC has recorded 36% increase in provisions to Rs 370 crore in Q3 FY26 from Rs 272 crore in Q3 FY25. Profit before tax for Q3 FY26 was Rs 328 crore as against Rs 91 crore in Q3 FY25. The company said that its asset quality remained stable, with GNPA at 2.6% and NNPA at 1.9% as on 31 December 2025. Total assets under management (AUM) grew by 23% YoY to Rs 96,690 crore as on 31 December 2025. The company's networth at the end of December'25 period was Rs 27,872 crore, with cash and liquid investments of Rs 7,504 crore. Anand Piramal, chairman, Piramal Finance, said: 'Q3 was another strong quarter, and it capped a very solid nine-month performance in FY26. We have also recently achieved a few important milestones. Earlier this month, we received a CRISIL AA+ rating for our long-term debt, which strengthens our ability to scale up responsibly and profitably. We also secured our inaugural DFI funding of $350 million from IFC and ADB ' an important validation of our business model, governance and long-term direction. This partnership also diversifies our funding sources and supports our growth plans. Alongside growth, we remain focused on strengthening our balance sheet. We recently monetised our stake in Shriram Life Insurance for Rs 600crore, expected to close in Q4. The consistency we have seen across the last several quarters gives us confidence in our direction and our ability to deliver sustained growth and profitability.' Piramal Finance is a retail-led upper layer NBFC with a pan-India presence, having served over 5 million customers across 26 states. In retail lending, the company offers home loans, loans against property, used car loans, personal loans, digital loans and small business loans. In wholesale lending, the company provides asset-backed, data-driven solutions across real estate and select non-real estate sectors. The scrip had declined 1.53% to end at Rs 1792.95 on the BSE on Friday. Powered by Capital Market - Live

Net profit of Cyber Media (India) reported to Rs 0.20 crore in the quarter ended December 2025 as against net loss of Rs 9.12 crore during the previous quarter ended December 2024. Sales rose 5.13% to Rs 25.01 crore in the quarter ended December 2025 as against Rs 23.79 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales25.0123.79 5 OPM %4.880.92 - PBDT1.440.01 14300 PBT1.37-0.07 LP NP0.20-9.12 LP Powered by Capital Market - Live